IS-free Treg HaploHCT
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Analysis of Risk in MDS Over Time - Comparison of Treated vs Untreated Patients
- Status
- COMPLETED
- Phase
- N/A
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
- Status
- COMPLETED
- Phase
- NA
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)
- Status
- UNKNOWN
- Phase
- N/A
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
- Status
- RECRUITING
- Phase
- NA
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Tolerability of EP0042
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT
- Status
- COMPLETED
- Phase
- PHASE2
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS
- Status
- SUSPENDED
- Phase
- PHASE1
Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA